Literature DB >> 3508217

Effects of meprobamate on plasma lipids, lipoproteins, and experimental atherosclerosis.

H Y Wong, K S Cheng, H S Kruth.   

Abstract

The effects of the tranquilizer meprobamate (Equanil) on plasma lipids, lipoproteins, and atherogenesis in cockerels fed an atherogenic diet have been investigated. Gross gradings (visually assessed blindly) of the atherosclerosis of the thoracic and abdominal aortas of the meprobamate-treated plain mash were significantly more severe than the untreated plain mash controls. There were no significant differences in the gradings of thoracic and abdominal aortic lesions in the atherogenic groups, whether treated with meprobamate or not. Microscopic examination of the coronary arteries of birds on the atherogenic regimen treated with meprobamate revealed that these birds had atherosclerosis similar to the atherogenic diet group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508217      PMCID: PMC2625582     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  23 in total

1.  Atherosclerosis in the chicken. Correlation of the arterial blood pressure and arterial changes in the chicken.

Authors:  A GROLLMAN; C ASHWORTH; W SUKI
Journal:  Arch Pathol       Date:  1963-06

2.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

3.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon; P M McNamara
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

Review 7.  Drug therapy. Benzodiazepines (first of two parts).

Authors:  D J Greenblatt; R I Shader
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

8.  Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique.

Authors:  B W Steele; D F Koehler; M M Azar; T P Blaszkowski; K Kuba; M E Dempsey
Journal:  Clin Chem       Date:  1976-01       Impact factor: 8.327

9.  Ischemic heart disease, atherosclerosis, and longevity.

Authors:  J W Gofman; W Young; R Tandy
Journal:  Circulation       Date:  1966-10       Impact factor: 29.690

10.  Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years.

Authors:  R H Rosenman; R J Brand; D Jenkins; M Friedman; R Straus; M Wurm
Journal:  JAMA       Date:  1975-08-25       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.